Chronic intestinal pseudoobstruction: Report of four pediatric patients

Turkish Journal of Gastroenterology

Volumn 16, Issue 2, 2005, Pages 93-97

  Dalgiç, Buket ^a,b   Sari, Sinan ^a   Doǧan, Ibrahim ^a   Ünal, Selahattin ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Children; Chronic intestinal pseudoobstruction; Octreotide

Indexed keywords

ERYTHROMYCIN; OCTREOTIDE; PROKINETIC AGENT;

ARTICLE; CASE REPORT; CHILDHOOD DISEASE; CHRONIC DISEASE; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HEART SURGERY; HUMAN; IDIOPATHIC DISEASE; INTESTINE MOTILITY; INTESTINE OBSTRUCTION; LABORATORY DIAGNOSIS; LAPAROTOMY; PSEUDOOBSTRUCTION; RARE DISEASE; SCHOOL CHILD; SYMPTOMATOLOGY;

ADOLESCENT; CHILD; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; ERYTHROMYCIN; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MALE; OCTREOTIDE; RADIOGRAPHY, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 22544474432     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rudolph CD, Hyman PE, Altschuler SM, et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997; 24: 102-12.
2. Smith DS, Williams CS, Ferris CD. Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction. Gastroenterol Clin N Am 2003; 32: 619-58.
3. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 980-7.
4. Thiel ER, Bircks W. Acute pseudo-obstruction of the colon (Ogilvie's syndrome) following open heart surgery. Thorac Cardiovasc Surg 1990 Dec; 38(6): 371-3.
5. Rohrman CA, Ricci MT, Krishnamurthy S, et al. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract. Visceral neuropathies and progressive systemic sclerosis. AJR 1984; 143: 933-41.
6. Faure C, Goulet O, Ategbo S, et al. Chronic intestinal pseudo-obstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. Dig Dis Sci 1999; 44: 953-9.
7. Almeida PS, Penna FJ. Chronic intestinal pseudo-obstruction in childhood - report of seven cases. J Pediatr 2000; 76: 453-7.
8. Goulet O, Talbotec C, Ricour JC. Nutritional management of pediatric patients with chronic intestinal pseudo-obstruction syndrome. J Pediatr Gastroenterol Nutr 2001; 32: 44-7.
9. Laustsen J, Harling H, Fallingborg J. Treatment of chronic idiopathic intestinal pseudo-obstruction. Dig Dis Sci 1987; 32: 222-3.
10. Berger SA, Keshavarzian A, DeMeo MT, et al. Erythromycin in chronic intestinal pseudo-obstruction. J Clin Gastroenterol 1990; 12: 363.
11. Camillieri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994; 106: 916-23.
12. Vargas JH, Sachs P, Ament ME. Chronic intestinal pseudoobstruction syndrome in pediatrics: results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1988; 7: 323-32.
13. Cucchiara S, Minella R, Scoppa A. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. J Pediatr Gastroenterol Nutr 1997; 24: 411-8.
14. Soudah HC, Hasler W, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 1461-7.
15. Marie I, Kerleau JM, Ducrotte P, et al. Intravenous immunoglobulins and octreotide as treatment of intestinal pseudo-obstruction revealing a recurrence of polymyositis. Rheumatology 2001; 40: 1072-3.
16. Perlemuter G, Cacoub P, Chaussade S, et al. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. Arthritis Rheum 1999; 42: 1545-9.
17. Owyang C. Octreotide in gastrointestinal motility disorders. Gut 1994; 35 (Suppl 3): 11-4.
18. Di Lorenzo C, Lucanto C, Flores AF, et al. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 1998; 27: 508-12.
19. Di Lorenzo C, Lucanto C, Flores AF, et al. Effect of sequential erythromycin and octreotide on antroduodenal manometry. J Pediatr Gastroenterol Nutr 1999; 29: 293-6.
20. Verne GN, Eaker EY, Hardy E, et al. Effect of octreotide and erythromycin on idiopathic and scleroderma associated intestinal pseudo-obstruction. Dig Dis Sci 1995; 40: 1892-1901.
21. Heneyke S, Smith W, Spitz L, et al. Chronic intestinal pseudo-obstruction: treatment and long term follow up of 44 patients. Arch Dis Child 1999; 81: 21-7.
22. Mousa H, Hyman PE, Cocjin J, et al. Long term outcome of chronic intestinal pseudoobstruction. Dig Dis Sci 2002; 47: 2298-2305.
23. Goulet O, Jobert-Giraud A, Michel JL, et al. Chronic intestinal pseudo-obstruction syndrome in pediatric patients. Eur J Pediatr Surg 1999; 9: 83-90.